Information for the public
Latanoprost–netarsudil (Roclanda) is available on the NHS. It is a possible treatment for reducing pressure inside the eye (also called intraocular pressure or IOP) in adults with primary open-angle glaucoma or high pressure inside the eye (ocular hypertension), if:
- a prostaglandin analogue alone has not reduced IOP enough, and:
- they have then tried a fixed-dose combination treatment and it has not reduced IOP enough, or
- a fixed-dose combination treatment containing beta-blockers is unsuitable.
If you are not eligible for latanoprost–netarsudil but are already having it, you should be able to continue until you and your doctor decide when best to stop.
Is this treatment right for me?
Your healthcare professionals should give you clear information, talk with you about your options and listen carefully to your views and concerns. Your family can be involved too, if you wish. See our webpage on making decisions about your care.
Questions to think about
- How well does it work compared with other treatments?
- What are the risks or side effects? How likely are they?
- How will the treatment affect my day-to-day life?
- What happens if the treatment does not work?
- What happens if I do not want to have treatment? Are there other treatments available?
Information and support
The NHS webpage on glaucoma may be a good place to find out more.
Glaucoma UK (01233 648170) can give you advice and support:
You can also get support from your local Healthwatch.
NICE is not responsible for the quality or accuracy of any information or advice provided by these organisations.
ISBN: 978-1-4731-6128-3
This page was last updated: